DONDERO JAMES D 13D and 13G filings for Paratek Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-03-11 4:15 pm Purchase |
2021-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK |
DONDERO JAMES D | 2,892,197 5.700% |
2,892,197 (New Position) |
Filing |